Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. William F. Feehery Ph.D. | CEO & Director | 1.32M | -- | 1971 |
| Mr. Leif E. Pedersen | President & Chief Commercial Officer | 609.11k | -- | 1965 |
| Mr. John E. Gallagher III | SVP, Principal Accounting Officer & Chief Financial Officer | 1.07M | -- | 1973 |
| Dr. Robert P. Aspbury Ph.D. | President of Certara Scientific Software | 552.23k | -- | 1972 |
| Dr. Patrick F. Smith Pharm.D. | Senior Vice President of Translational Sciences | 582.02k | -- | 1971 |
| Mr. Daniel Corcoran | Chief Counsel | -- | -- | -- |
| Mr. Ron DiSantis | Senior Vice President of Corporate Development | -- | -- | -- |
| Ms. Sheila Rocchio MBA | Chief Marketing Officer | -- | -- | -- |
| Ms. Rona Anhalt | Chief Human Resources Officer | -- | -- | 1965 |
| Dr. Frederic Yves Bois | Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board | -- | -- | -- |
Certara, Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
- Full Time Employees:
- 1,487
Description
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Corporate Governance
Upcoming Events
May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC
Certara, Inc. Earnings Date
Recent Events
December 16, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission